PCOS Work-Up in Reproductive-Age Women
Diagnose PCOS when two of three criteria are met: androgen excess, ovulatory dysfunction, or polycystic ovaries on ultrasound—but first exclude thyroid disease, hyperprolactinemia, and nonclassic congenital adrenal hyperplasia in all women. 1
Essential Diagnostic Criteria
The Rotterdam criteria require any 2 of 3 findings 1:
- Androgen excess (clinical or biochemical)
- Ovulatory dysfunction (oligomenorrhea/amenorrhea)
- Polycystic ovaries on ultrasound
Critical Exclusions (Must Rule Out First)
Mandatory screening for all women 1:
- TSH → exclude thyroid disease
- Prolactin → exclude hyperprolactinemia
- 17-hydroxyprogesterone (17-OHP) → exclude nonclassic congenital adrenal hyperplasia (21-hydroxylase deficiency)
Additional exclusions in select women with amenorrhea or severe phenotypes 1:
- Cushing syndrome
- Androgen-secreting tumors
- Other causes of anovulation
Physical Examination Components
Document the following 1:
- Terminal hair growth (hirsutism—use standardized scoring)
- Acne distribution and severity
- Alopecia (androgenic pattern)
- Acanthosis nigricans (neck, axillae, groin)
- Skin tags
- BMI and waist circumference (abdominal adiposity assessment)
Laboratory Work-Up
Androgen Assessment
Measure circulating androgens 1, 2:
- Total and free testosterone
- Sex hormone-binding globulin (SHBG)
- Consider DHEA-S if virilization present
Ovulatory Status
- Menstrual history is primary screening tool 1
- Midluteal progesterone if eumenorrheic but anovulation suspected 1
Metabolic Screening
Oral glucose tolerance test (OGTT) with insulin levels 1—this is critical as women with PCOS have increased risk of type 2 diabetes and metabolic syndrome
Imaging
Transvaginal ultrasound for polycystic ovary morphology 1, 2
- Not required if both androgen excess and ovulatory dysfunction already present
- Do NOT use ultrasound for endometrial thickness screening routinely 1
Special Population: Adolescents (Ages 15-19)
- Clinical and/or biochemical hyperandrogenism (after exclusion of other pathologies)
- Persistent oligomenorrhea (irregular cycles beyond 2 years post-menarche)
- Anovulatory symptoms alone (normal in early puberty)
- Polycystic ovary morphology alone (common in normal adolescent development)
- AMH levels (limited specificity in adolescents) 4
Additional Screening Based on Risk Profile
Mental Health
Screen by history for 1:
- Depression
- Anxiety Refer for treatment if identified
Sleep Disorders
In overweight/obese women, screen for 1:
- Obstructive sleep apnea symptoms
- Obtain polysomnography if positive
Fertility Assessment
If seeking pregnancy 1:
- Confirm ovulatory status
- Exclude other infertility causes beyond anovulation (tubal factors, male factor, etc.)
Metabolic Monitoring
- Do NOT routinely screen for NAFLD/NASH 1
- Do screen for obesity, insulin resistance, and diabetes risk
Common Pitfalls to Avoid
Overdiagnosis in adolescents: Irregular cycles and polycystic ovaries are physiologic in early puberty—require persistent findings 1, 3
Missing alternative diagnoses: Always exclude thyroid disease, hyperprolactinemia, and CAH before confirming PCOS 1
Relying on ultrasound alone: PCO morphology without clinical/biochemical findings is insufficient 1
Neglecting metabolic screening: OGTT is recommended, not just fasting glucose 1
Forgetting mental health: Depression and anxiety are significantly increased—screen proactively 1